1.江苏医药职业学院,江苏 盐城 224005
2.盐城市第一人民医院,江苏 盐城 224006
3.南京中医药大学 盐城附属医院,江苏 盐城 224001
冯华,博士,副主任医师,副教授,从事不孕症及其合并症的基础和临床研究,E-mail:fenghua198209@126.com
收稿:2024-06-24,
录用:2024-08-14,
网络出版:2024-08-26,
纸质出版:2025-03-05
移动端阅览
冯华,许丹,洪学兰.宁心疏肝汤联合拮抗剂固定方案对多囊卵巢综合征不孕患者IVF-ET结局及血清神经肽吻素表达影响[J].中国实验方剂学杂志,2025,31(05):177-184.
FENG Hua,XU Dan,HONG Xuelan.Effects of Ningxin Shugan Decoction Combined with Antagonist Fixation Regimen on IVF-ET Outcomes and Serum Kisspeptin Expression in Infertility Patients with Polycystic Ovary Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):177-184.
冯华,许丹,洪学兰.宁心疏肝汤联合拮抗剂固定方案对多囊卵巢综合征不孕患者IVF-ET结局及血清神经肽吻素表达影响[J].中国实验方剂学杂志,2025,31(05):177-184. DOI: 10.13422/j.cnki.syfjx.20250194.
FENG Hua,XU Dan,HONG Xuelan.Effects of Ningxin Shugan Decoction Combined with Antagonist Fixation Regimen on IVF-ET Outcomes and Serum Kisspeptin Expression in Infertility Patients with Polycystic Ovary Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):177-184. DOI: 10.13422/j.cnki.syfjx.20250194.
目的
2
探讨宁心疏肝汤联合拮抗剂固定方案对多囊卵巢综合征不孕患者体外受精-胚胎移植(IVF-ET)结局及血清神经肽吻素(kisspeptin)表达影响。
方法
2
选择于盐城市第一人民医院及南京中医药大学盐城附属医院就诊的多囊卵巢综合征不孕患者96例,采用简单化随机分组方法分为观察组与对照组,各48例,对照组患者给予拮抗剂固定方案辅助生殖治疗,观察组在其基础上给予宁心疏肝汤治疗,对比两组患者治疗前后的临床疗效,中医证候总积分及中医单项证候积分,促排情况,血清生殖激素水平,血清miR-335-5p、miR-141-3p,kisspeptin,IVF-ET结局指标及安全性评价。采用Pearson检验对血清促卵泡生成素(FSH)、kisspeptin水平、血清miR-335-5p、miR-141-3p与IVF-ET结局指标进行相关性分析。
结果
2
治疗后观察组总有效率为90.91%,明显优于对照组的70.45%,差异有统计学意义(
P
<
0.05)。与本组治疗前比较,治疗后两组中医证候总积分和中医单项证候积分、睾酮、促黄体生成素(LH)及LH/FSH水平均明显降低(
P
<
0.05),且观察组低于对照组(
P
<
0.05)。治疗后两组FSH、血清kisspeptin水平、血清miR-335-5p、miR-141-3p表达水平均明显升高,且观察组高于对照组(
P
<
0.05)。观察组促排后的获卵数、MⅡ卵数、胚胎种植率、临床妊娠率、活产率均高于对照组(
P
<
0.05,
P
<
0.01)。血清FSH、kisspeptin、miR-335-5p、miR-141-3p水平均与胚胎种植率、临床妊娠率、活产率呈正相关(
P
<
0.01)。
结论
2
宁心疏肝汤联合拮抗剂固定方案可改善多囊卵巢综合征不孕患者IVF-ET结局,提高血清kisspeptin表达,提高排卵率和妊娠率。
Objective
2
To investigate the effects of Ningxin Shugan decoction combined with an antagonist fixation regimen on
in vitro
fertilization and embryo transfer (IVF-ET) outcomes and serum kisspeptin expression in infertility patients with polycystic ovary syndrome.
Methods
2
A total of 96 infertile patients with polycystic ovary syndrome treated in Yancheng No.1 People's Hospital and Yancheng Affiliated Hospital of Nanjing University of Chinese Medicine were enrolled in this study and randomized into control and observation groups (
n
=48). The control group was treated with an antagonist fixation regimen, and the observation group was treated with Ningxin Shugan decoction on the basis of the treatment in the control group. The clinical efficacy was compared between the two groups. The total score and single scores of TCM symptoms, ovulation promotion status, and serum levels of reproductive hormones, miR-335-5p, miR-141-3p, and kisspeptin were determined before and after treatment. The IVF-ET outcome indicators and treatment safety were evaluated. Pearson test was conducted to analyze the correlations of serum levels of follicle-stimulating hormone (FSH), kisspeptin, miR-335-5p, and miR-141-3p with IVF-ET outcomes.
Results
2
The total response rate in the observation group was 90.91%, which was higher than that (70.45%) in the control group (
P
<
0.05). The total score and single scores of TCM symptoms and the testosterone, luteinizing hormone (LH), and LH/FSH levels declined after treatment (
P
<
0.05), and they were lower in the observation group than in the control group (
P
<
0.05). After treatment, the serum levels of FSH, kisspeptin, miR-335-5p, and miR-141-3p rose in both groups, being higher in the observation group than in the control group (
P<
0.05). The observation group showed higher o
vulation number, number of MⅡ oocytes, embryo implantation rate, clinical pregnancy rate, and live birth rate than the control group (
P
<
0.05,
P
<
0.01). Serum levels of FSH, kisspeptin, miR-335-5p, and miR-141-3p were positively correlated with embryo implantation rate, clinical pregnancy rate, and live birth rate (
P
<
0.01).
Conclusion
2
Ningxin Shugan decoction combined with the antagonist fixation regimen can improve the IVF-ET outcome, promote the serum kisspeptin expression, and increase the ovulation rate and pregnancy rate in infertility patients with polycystic ovary syndrome.
TEEDE H J , TAY C T , LAVEN J , et al . Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome [J]. J Clin Endocrinol Metab , 2023 , 108 ( 10 ): 2447 - 2469 .
DI LORENZO M , CACCIAPUOTI N , LONARDO M S , et al . Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS):A comprehensive review [J]. Curr Nutr Rep , 2023 , 12 ( 3 ): 527 - 544 .
ARU N , YANG C , CHEN Y , et al . Causal association of immune cells and polycystic ovarian syndrome:A Mendelian randomization study [J]. Front Endocrinol (Lausanne) , 2023 , 14 : 1326344 .
FENG Y , TANG Z , ZHANG W . The role of macrophages in polycystic ovarian syndrome and its typical pathological features:A narrative review [J]. Biomed Pharmacother , 2023 , 167 : 115470 .
于文澔 , 张倩 , 孙梅 , 等 . 激动剂长方案与拮抗剂方案对胚胎整倍体率的影响 [J]. 山东大学学报:医学版 , 2023 , 61 ( 1 ): 45 - 50 .
YU W H , ZHANG Q , SUN M , et al . Comparison of the euploidy rate of PGT-A tested embryos between long GnRH agonist and GnRH antagonist protocols [J]. J Shandong Univ:Health Sci , 2023 , 61 ( 1 ): 45 - 50 .
曾汝君 , 陈晗笑 , 秦朗 , 等 . 主流促排方案在多囊卵巢综合征患者中辅助助孕的结局比较 [J]. 实用医院临床杂志 , 2021 , 18 ( 6 ): 50 - 54 .
ZENG R J , CHEN H X , QIN L , et al . Comparison of outcomes of different controlled ovarian stimulation protocols for infertility treatment in patients with polycystic ovary syndrome [J]. Prac J Clin Med , 2021 , 18 ( 6 ): 50 - 54 .
谈勇 , 王如芯 , 邹奕洁 , 等 . 中医药在辅助生殖技术治疗不孕症中的协同作用探赜 [J]. 江苏中医药 , 2023 , 55 ( 9 ): 1 - 7 .
TAN Y , WANG R X , ZOU Y J , et al . Exploring the synergistic effect of traditional Chinese medicine in the treatment of infertility with assisted reproductive technology [J]. Jiangsu J Tradit Chin Med , 2023 , 55 ( 9 ): 1 - 7 .
张晶晶 , 朱冉冉 , 刘娜 , 等 . 基于"情志致病"理论探究丹栀逍遥丸联合治疗肝郁证多囊卵巢综合征所致不孕症的效果 [J]. 临床误诊误治 , 2024 , 37 ( 6 ): 77 - 81 .
ZHANG J J , ZHU R R , LIU N , et al . Effect of combined treatment with Danzhi Xiaoyao pills on infertility caused by liver-depression type of polycystic ovary syndrome based on the theory of emotional pathogenesis [J]. Clin Misdiagno Misther , 2024 , 37 ( 6 ): 77 - 81 .
杨贞 , 陈谋 , 江少如 , 等 . 益气血法经后增殖方在多囊卵巢综合征患者促排卵中的临床疗效研究 [J]. 广州中医药大学学报 , 2024 , 41 ( 4 ): 894 - 899 .
YANG Z , CHEN M , JIANG S R , et al . Clinical observation on the effect of postmenstrual proliferative prescription through replenishing Qi and blood on ovulation induction in patients with polycystic ovarian syndrome [J]. J Guangzhou Univ Tradit Chin Med , 2024 , 41 ( 4 ): 894 - 899 .
ATAKUL N , KILIC B S , SELEK S , et al . Kisspeptin:A potential therapeutic target in patients with unexplained infertility? [J]. Ir J Med Sci , 2023 , 192 ( 4 ): 1779 - 1784 .
中华医学会妇产科学分会内分泌学组及指南专家组 . 多囊卵巢综合征中国诊疗指南 [J]. 中华妇产科杂志 , 2018 , 53 ( 1 ): 2 - 6 .
Endocrinology Group and Guideline Expert Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association . Chinese diagnosis and treatment guidelines for polycystic ovary syndrome [J]. Chin J Obstet Gynecol , 2018 , 53 ( 1 ): 2 - 6 .
陈子江 , 刘嘉茵 , 黄荷凤 , 等 . 不孕症诊断指南 [J]. 中华妇产科杂志 , 2019 , 54 ( 8 ): 505 - 511 .
CHEN Z J , LIU J Y , HUANG H F , et al . Infertility diagnostic guidelines [J]. Chin J Obstet Gynecol , 2019 , 54 ( 8 ): 505 - 511 .
马宝璋 , 齐聪 . 中医妇科学 [M]. 北京 : 中国中医药出版社 , 2012 : 227 .
MA B Z , QI C . Gynecology of traditional Chinese medicine [M]. Beijing : China Press of Chinese Medicine , 2012 : 227 .
中国食品药品监督管理局 . 中药新药临床研究指导原则(试行) [M]. 北京 : 中国医药科技出版社 , 2002 : 241 .
China Food and Drug Administration . Guidelines for clinical research of traditional Chinese medicine new drugs (Trial) [M]. Beijing : China Health Media Group , 2002 : 241 .
刘博文 , 包淑婷 , 杨亦青 , 等 . 不同促排卵方案对多囊卵巢综合征患者IVF-ET妊娠结局的影响 [J]. 生殖医学杂志 , 2019 , 28 ( 12 ): 1396 - 1401 .
LIU B W , BAO S T , YANG Y Q , et al . Comparison of pregnancy outcomes of three controlled ovarian stimulation protocols for patients with polycystic ovary syndrome [J]. J Reprod Med , 2019 , 28 ( 12 ): 1396 - 1401 .
NAVARRO V M . Metabolic regulation of kisspeptin - The link between energy balance and reproduction [J]. Nat Rev Endocrinol , 2020 , 16 ( 8 ): 407 - 420 .
TSOUTSOUKI J , PATEL B , COMNINOS A N , et al . Kisspeptin in the prediction of pregnancy complications [J]. Front Endocrinol (Lausanne) , 2022 , 13 : 942664 .
邵洋 , 姚超 , 徐崧圆 , 等 . 多囊卵巢综合征患者血清神经调节蛋白4水平与性激素及代谢水平的相关性分析 [J]. 实用临床医药杂志 , 2024 , 28 ( 10 ): 112 - 115 .
SHAO Y , YAO C , XU S Y , et al . Correlation of serum neuregulin 4 level with sex hormone and metabolism level in patients with polycysticovary syndrome [J]. J Clin Med Prac , 2024 , 28 ( 10 ): 112 - 115 .
ZHANG S , LIU Y , WANG M , et al . Role and mechanism of miR-335-5p in the pathogenesis and treatment of polycystic ovary syndrome [J]. Transl Res , 2023 , 252 : 64 - 78 .
FAN L , WANG C , ZHAN P , et al . miR-141-3p is poorly expressed in polycystic ovary syndrome and correlates with glucose and lipid metabolism [J]. Int J Endocrinol , 2021 , 2021 : 2022938 .
范明皓 , 莫蕙 , 徐广飞 , 等 . 多囊卵巢综合征患者血清miR-335-5p、miR-141-3p水平变化及其诊断价值 [J]. 疑难病杂志 , 2024 , 23 ( 6 ): 708 - 713 .
FAN M H , MO H , XU G F , et al . Changes in serum miR-335-5p and miR-141-3p levels in patients with polycystic ovary syndrome and their diagnostic value [J]. Chin J Diffic Complicat Case , 2024 , 23 ( 6 ): 708 - 713 .
徐秀梅 , 刘文建 . 香附药理作用及临床应用的进展 [J]. 广东化工 , 2023 , 50 ( 9 ): 122 - 123,69 .
XU X M , LIU W J . Research progress of clinical application and of cyperus rotundus [J]. Guangdong Chem Ind , 2023 , 50 ( 9 ): 122 - 123,69 .
何越 , 林丽娜 , 张天婵 , 等 . 基于中医心身医学理论探讨妇科疾病治疗 [J]. 辽宁中医杂志 , 2023 , 50 ( 7 ): 66 - 69 .
HE Y , LIN L N , ZHANG T C , et al . Discussion on treatment of gynecological diseases based on TCM psychosomatic medicine theory [J]. Liaoning J Tradit Chin Med , 2023 , 50 ( 7 ): 66 - 69 .
尹彤 , 韩学杰 , 王丽颖 , 等 . 韩学杰"双轴理论"诊治不孕症新思路的探析 [J]. 世界中西医结合杂志 , 2022 , 17 ( 9 ): 1894 - 1898 .
YIN T , HAN X J , WANG L Y , et al . Professor HAN Xuejie's new ideas for diagnosis and treatment of infertility from the "biaxial theory" [J]. World J Integr Tradit West Med , 2022 , 17 ( 9 ): 1894 - 1898 .
0
浏览量
136
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
